Tardigrade Antifreeze Mechanism Achieves 89% Red Blood Cell Recovery
Release time:
2026-10-19
In cryomedicine, how to minimize damage to cells throughout freezing, transport, and thawing has long been an unavoidable challenge. The American Chemical Society (ACS) recently announced that a study published in ACS Applied Materials & Interfaces applied the extreme-environment survival strategies of tardigrades (commonly known as water bears) to red blood cell cryopreservation and restored red blood cell counts in an anemic mouse model.
Why Tardigrade Survival Mechanisms Are Worth Learning From
Tardigrades are known for their extraordinary tolerance: freezing, dehydration, and even the vacuum of space cannot harm them. Researchers have even given them tiny tattoos, and these small creatures seem not to mind at all. Understanding their survival mechanisms under extreme conditions has thus become one approach to protecting human cells.
One potential application is red blood cell cryopreservation—long-term storage of rare blood types for use when clinically needed. The conventional approach treats blood cells with glycerol to inhibit ice crystal formation during freezing. However, glycerol must be removed before transfusion, and the removal process itself causes cell damage. Tardigrades offer a simpler path: they contain a protein called CAHS (cytosolic abundant heat-soluble protein), which helps maintain their state under extreme conditions; these proteins can also interact uniquely with trehalose (a sugar that stabilizes cell membranes and proteins and is often used to reduce freeze damage in frozen foods).
Based on this, the research team hypothesized: could combining CAHS protein with trehalose protect red blood cells better than glycerol alone? The researchers did not use full-length CAHS protein; instead, they determined that a fragment of it was sufficient to provide the desired protection. This fragment binds with trehalose at low temperature and is then frozen in liquid nitrogen, altering the way ice forms and melts, thereby protecting the cells.
Up to 89% Complete Recovery Rate
After thawing, the CAHS–trehalose combination can be easily washed away by centrifugation. Data showed that up to 89% of mouse red blood cells preserved by the new method recovered completely, compared with about 82% for cells frozen with glycerol.
The research team then conducted biocompatibility tests on the new approach, confirming that blood cells still had good biocompatibility after freezing, thawing, and washing. In anemic mice, transfusion of blood cryopreserved by this method significantly improved red blood cell counts and hemoglobin levels without triggering an inflammatory response.
The researchers said this is the first attempt to translate survival lessons from an extremely tolerant organism into a practical cell preservation strategy. If further developed, this technology could simplify post-thaw processing, reduce concerns about residual glycerol, and help maintain the quality of stored cells.
The research team hopes this work will help design better cryopreservation strategies and even advance blood preservation solutions that can maintain function at room temperature.
Paper information: A Tardigrade-Derived CAHS-Motif Enables Glycerol-Free Red Blood Cell Cryopreservation with Enhanced Low-Temperature Trehalose Loading and Synergistic Suppression of Ice Damage, ACS Applied Materials & Interfaces. The research was supported by the National Natural Science Foundation of China, the Guangdong Basic and Applied Basic Research Foundation, and the Shaanxi Provincial Natural Science Basic Research Program.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
